Jubilant Organosys's US based subsidiary Draximage LLC has received US FDA approval for its ANDA for Draximage's generic Sestamibi. The product is found to be bioequivalent and therapeutically equivalent to reference listed drug Cardiolite.
The details can be read here.
No comments:
Post a Comment